$40M Defense Subcontract Lands Alongside Q1 Beat — Product +28% YoY, Gross Margin 52.7%, Stock +38.6% T+1 on Historic 30x Volume; Upgrading to Outperform

Results vs. Consensus

Year-over-Year Comparison

Quarter-over-Quarter Comparison

Revenue Assessment

The Q1 print at $14.9M is the cleanest demonstration to date that Everspin's multi-quarter product acceleration has resumed. MRAM product sales of $14.1M (+28% YoY; +5% QoQ) is the strongest YoY product growth quarter of our four-quarter coverage period — up from the +22% YoY trajectory of Q3-Q4 2025. The composition is structurally diversified: Industrial Automation recovery (Japan in particular as the Asia inventory destock completed); Transportation/Rail (two new Asia design wins for axle counter applications); Data Center (IBM FCM4 + FCM5 + top-5 hyperscale RAID reference design); LEO satellite continuing; and ongoing automotive (Lucid Gravity SUV).

The licensing/royalty/patent/other line declined to $0.8M from Q4's $1.3M — meeting the CFO's Q4 commentary about the QuickLogic-related project completion. The line is now at the structural floor (~5% of revenue); further decline would require new project completions without new contract additions. The newly-announced $40M defense subcontract is reported alongside Toggle MRAM (in the product side) plus engineering services (likely some in the licensing line). Initial revenue recognition starts in Q2; the Q2 guide of $15.5-16.5M EXCLUDES any new-subcontract contribution.

The Q2 26 guide of $15.5-16.5M (+7% QoQ at midpoint, +4-11% QoQ range) is the cleanest sequential acceleration signal we have. Excluding subcontract, Q2 will print at $16M+ if the trajectory holds. Including subcontract, Q2 could land at $16.5-17.5M. We model FY26 revenue at $65-72M (vs FY25 ~$55M; +18-31% YoY) — a meaningful step up from the Q4-recap FY26 estimate of $58-62M.

Margin Assessment

GAAP gross margin of 52.7% is the operational surprise of the quarter — Q4 commentary had explicitly guided to gross margin "headwind" with the 50% range as the target. The actual print expanded +190bps QoQ. The CFO attributed it to higher capacity utilization + continued yield improvements. This is structurally meaningful: management has consistently anchored expectations at 45-50% as the structural product gross margin range; the actual Q1-Q4 2025 trajectory has been 51.4% → 51.3% → 51.3% → 50.8% → 52.7% Q1 2026. Five consecutive quarters above 50%, with Q1 2026 the highest of the run. Either the structural floor is materially higher than 45-50%, or the licensing mix has stabilized at a higher contribution level than management's framing suggested.

GAAP OpEx of $10.6M (+23% QoQ; +22% YoY) reflects (a) $1.6M of patent litigation costs (now formally excluded from non-GAAP), (b) higher compensation costs for new and existing employees, and (c) higher professional fees (legal + accounting). Stripping litigation, non-GAAP OpEx is ~$9M — a step-up from Q4's ~$7M but consistent with the planned acceleration in commercial-team hiring + AI/cloud R&D investment. The structural OpEx run-rate for FY26 is likely $9-10M per quarter (ex-litigation), supporting non-GAAP EBITDA margins of 25-30% at the Q2 revenue level.

EPS & Cash Flow Assessment

Non-GAAP EPS of $0.11 (at the high end of $0.07-0.12 guide) is the second consecutive quarter at this level — and meaningfully above Q1 2025's $0.02 (5x lift YoY). The non-GAAP framework now formally excludes patent litigation costs in addition to SBC, recognizing the discrete nature of the litigation expense. GAAP EPS of $(0.80) reflects (a) $1.6M litigation drag, (b) $2.5M+ SBC, and (c) below-the-line other expenses. The GAAP-to-non-GAAP bridge has widened materially with the litigation reclassification — the Q1 $(0.80) GAAP EPS appears alarming but is artifact of the legal cost timing.

Cash position declined $4M sequentially to $40.5M — the second consecutive quarterly cash decline and the steepest of the trailing year. Drivers: operating CF of $0.5M (down from Q4 $2.8M on litigation + working capital), capex elevated ($3-4M for Microchip Foundry Services + Chandler facility), and litigation cash outflow. The CFO's framework for FY26 cash: "We believe our cash and cash equivalents are sufficient to meet our anticipated capital requirements to execute upon our Foundry Services Agreement with Microchip and continue to invest in product development to support our future road map and enable the company to drive growth." Translation: we have enough cash for the current spend plan but cash will decline through FY26.

The $40M defense subcontract introduces a new cash flow consideration — service revenue (engineering services for the prime contractor) typically converts to cash within 30-60 days. If revenue recognition begins in Q2 at $1-2M / quarter, that's $4-8M of new operating cash flow annually as the subcontract scales — partially offsetting the FY26 capex pressure.

Segment Performance

MRAM Product Sales — $14.1M, +28% YoY, +5% QoQ (strongest YoY product growth of coverage period)

The product line growth at +28% YoY is the structural acceleration the multi-quarter narrative has been building toward. The composition this quarter introduces two new vertical strengths: (1) Industrial Automation recovery extending into Japan specifically — the inventory destocking cycle that affected H1 2025 demand has now fully completed; (2) Transportation/Rail applications — two newly disclosed Asia design-win customers using Everspin's MRAM for axle counter applications.

The CEO's commentary on the Rail/Transportation vertical was the most detailed end-market disclosure of the call:

"In the Transportation segment, growth was driven by the transition of design wins to production at several customers, including 2 rail applications. One such customer is a railroad operator in Asia, who is utilizing our MRAM technology for critical railway signal applications such as train axle counters. Axle counters and by extension, their components must operate in harsh, vibratory conditions, which MRAM can withstand better than other memory technologies. Modern axle counters use MRAM for storing large amounts of diagnostic and maintenance data, allowing for real-time monitoring such as wheel detection and predictive maintenance. Additionally, MRAM enables more robust data storage, contributing to the high safety integrity levels, SIL4, required for axle counter systems, ensuring accurate detection and reducing false alarms. Another customer is a leading embedded computing company in Asia who chose Everspin's MRAM solutions for rail transit systems because they reliably preserve critical data during power loss and support unlimited erase and write cycles." — Sanjeev Aggarwal, CEO

The Data Center contribution continues strong with the IBM FCM4 ongoing + the new FCM5 module + the "top-5 hyperscale operators" RAID reference design — the disclosure of "top-5 hyperscale operators" is a meaningful breadth signal (suggests Everspin parts are designed into multiple Cloud-Provider RAID architectures).

Assessment: The product line +28% YoY is structurally validating. The vertical diversification (Industrial + Transportation/Rail + Data Center + LEO + Defense) reduces concentration risk. The Q2 26 guide implies continued mid-teens YoY product growth ($15.5-16.5M total = ~$14.5-15.5M product = +25-35% YoY). We model FY26 product revenue at $58-65M (vs FY25 ~$48M, +21-35% YoY).

Defense Subcontract — $40M / 2.5 Years (NEW)

The single most strategically important disclosure of the call. The CEO opened the prepared remarks with the announcement before discussing the Q1 print itself — signaling its priority. The details disclosed:

"Before I discuss our first quarter results, I would like to share some exciting news. Today, after market close, we announced a new 2.5-year $40 million agreement with the U.S. prime contractor. Under the agreement, Everspin will be a subcontractor on an existing prime contract and will provide Toggle MRAM process technology capabilities and engineering services for U.S. defense industrial-based customers. In addition, Everspin will provide engineering and foundry services for U.S. Department of War or DoW products through its recently announced Foundry Services Agreement with Microchip. This agreement builds on our long history of supporting military and aerospace applications where performance, reliability, longevity and domestic production are critical." — Sanjeev Aggarwal, CEO

The structural implications:

• Revenue magnitude: $40M / 2.5 years = $16M annualized = ~30% lift to current quarterly revenue run-rate. If recognized linearly, that's $4M per quarter incremental revenue starting Q2 or Q3 2026.
• Revenue composition: Toggle MRAM process technology + engineering services. The "engineering services" component likely carries higher gross margin than product (60-80%+ gross margin) — meaningful for the consolidated margin profile.
• Strategic value beyond revenue: The agreement validates Everspin's positioning as the U.S. government-designated domestic Toggle MRAM source. The CEO disclosed that the prime contractor receives "right to second source the Everspin Toggle MRAM for mil/aero applications again in case Everspin decides to exit the business" — meaning Everspin retains the production but provides the prime with strategic supply-chain redundancy. This is the kind of relationship that compounds into multi-decade defense-industrial partnerships.
• Microchip Foundry Services integration: The new subcontract also leverages the Microchip Foundry Services Agreement (10-year, MRAM line at Microchip's Oregon fab) for product qualification. The two agreements work together — defense customers get a domestically-manufactured MRAM solution with supply-chain redundancy (Everspin Chandler + Microchip Oregon).

Assessment: The $40M subcontract is the structural thesis-changing event we have been waiting for since initiating coverage. It validates the multi-quarter narrative that Everspin's DoD relationship would compound into broader defense-industrial contracts. We model the subcontract at $4M per quarter starting Q3 26 (Q2 will be ramp-up), contributing $12-16M to FY26 revenue and $16M annualized through FY28. Combined with the multi-year Microchip Foundry Services Agreement (first products H2 2027) and the original DoD sustainment contract (completing H1 2027), Everspin now has the structural defense-industrial relationship moat that justifies a meaningfully higher multi-year multiple.

Licensing/Royalty/Patent/Other — $0.8M (Structural Floor)

The licensing line at $0.8M is at the structural floor as the QuickLogic-related project completed in Q1. The CFO's framing: "Licensing, royalty, patent and other revenue decreased to $0.8 million from $2.1 million in Q1 '25 due to fewer currently active projects." Going forward, the $0.8-1.0M quarterly run-rate is the structural baseline pending new contract additions.

The good news is that the $40M defense subcontract introduces a new "engineering services" component that likely flows partially into licensing/services revenue lines. Quarterly classification will be disclosed in Q2 results; if $1-2M of the new subcontract is recognized through licensing/services line, the line recovers to $1.5-2.5M run-rate.

Assessment: Licensing has reached the structural floor; further decline is unlikely. The new defense subcontract should provide partial recovery. We model FY26 licensing at $4-6M total (vs FY25 ~$7M, -15-40% YoY), with FY27 stable-to-growing as new contracts replace expiring ones.

Key Topics & Management Commentary

Overall Management Tone: Management's tone shifted markedly from Q4. The CEO opened with the $40M subcontract announcement before any other content — signaling the strategic priority and the structural significance. The framing was confident throughout: "we are pleased to report results at the high end of our guidance range," "growth was driven by strength in Industrial Automation, Transportation and Data Center applications," "we believe our cash and cash equivalents are sufficient to meet our anticipated capital requirements." The CFO matched the confidence with explicit Q2 sequential acceleration guidance + the disclosure that the new subcontract is NOT in the Q2 guide (preserving upside). The most forward-leaning disclosure was on the multi-year strategic positioning — Microchip Foundry Services creating a second domestic source, UNISYST family formally introduced at Embedded World, and the chiplet/AI-edge ecosystem positioning continuing to build. There were no defensive callouts; the tone was structurally constructive throughout.

1. $40M Defense Subcontractor Agreement — The Thesis-Changing Event

The most important disclosure of the call, addressed in the opening of the CEO's prepared remarks before Q1 results. The 2.5-year agreement with a U.S. prime contractor positions Everspin as a subcontractor providing Toggle MRAM process technology + engineering services for U.S. defense industrial-based customers.

"Before I discuss our first quarter results, I would like to share some exciting news. Today, after market close, we announced a new 2.5-year $40 million agreement with the U.S. prime contractor. Under the agreement, Everspin will be a subcontractor on an existing prime contract and will provide Toggle MRAM process technology capabilities and engineering services for U.S. defense industrial-based customers." — Sanjeev Aggarwal, CEO

The CEO's detailed framing of how this relates to other Everspin contracts: "the RFI for the 300-millimeter MRAM line is independent of the 3 other items you mentioned, namely the $14.6 million contract that we got in 2024, the Microchip Foundry Services Agreement and the new contract that we just talked about today." Translation: this $40M is its OWN contract — distinct from (a) the existing DoD sustainment contract, (b) the Microchip Foundry Services Agreement, and (c) any potential 300mm MRAM line work.

The strategic content: "Everspin will provide a technology information, a recipe, a compendium, if you will, for mil and aerospace Toggle MRAM to this contractor, to this U.S. prime contractor, okay? And in addition, they would have a right to second source the Everspin Toggle MRAM for mil/aero applications again in case Everspin decides to exit the business... and then also under this agreement, they actually get access to this Microchip fab that we are bringing up to qualify their existing products on that line. So there's NRE associated with getting that activity done. And then finally, there is a new product that the U.S. government is actually planning to tape out. So the R&D for that product and the production support for that product would also be part of this contract that we just talked about." — explaining three distinct revenue components within the subcontract.

Assessment: The $40M subcontract is the structural moat-building event we have been monitoring for. The 2.5-year term provides revenue visibility through mid-2028. The multi-component structure (technology recipe + Microchip qualification + new product NRE) suggests high-margin service revenue economics. Combined with the Microchip Foundry Services Agreement and the original DoD contract, Everspin's defense-industrial positioning is now structurally validated.

2. Industrial Automation Recovery Including Japan

The CEO disclosed that Industrial Automation growth in Q1 was driven by recovery in customer demand "including Japan, as inventory levels have been worked down." This is the structural completion of the Asia inventory destocking narrative that began in Q2 2025 and continued through Q3-Q4. With Japan now also normalizing, the Industrial Automation vertical should sustain at growth rates closer to normal end-market demand through FY26.

"Our performance this quarter was driven by strength in Industrial Automation, Transportation and Data Center applications. Industrial Automation growth was driven by a recovery in customer demand, including Japan, as inventory levels have been worked down." — Sanjeev Aggarwal, CEO

Assessment: Industrial Automation is structurally recovered. We model the vertical contributing $10-15M of FY26 revenue, growing 10-15% YoY off the FY25 base of ~$9-12M.

3. Transportation/Rail — New Vertical with SIL4 Safety Use Case

The Transportation segment is a newly disclosed vertical for Everspin's MRAM. Two named design-win customers in Asia: a railroad operator using MRAM for axle counter applications (SIL4 safety integrity level required), and an embedded computing company using MRAM for rail transit systems. The CEO's detailed framing of the axle counter use case (harsh vibratory conditions; large diagnostic data storage; real-time monitoring; predictive maintenance) demonstrates that MRAM has structural technical advantages in this application.

SIL4 (Safety Integrity Level 4) is the highest safety-integrity-level classification under IEC 61508 — used for railway signaling, nuclear safety systems, and the most safety-critical industrial applications. MRAM's combination of unlimited erase/write cycles + harsh-environment tolerance + persistent storage at power-loss makes it uniquely suited to SIL4 applications.

Assessment: Transportation/Rail is a new vertical for Everspin and represents structural TAM expansion. We don't size the FY26 contribution yet but treat it as a 2027+ revenue acceleration lever. The SIL4 application set has high barriers to entry (qualification cycles, regulatory approval), making it a defensible long-term revenue source.

4. Data Center: IBM FCM5 + Top-5 Hyperscale RAID Reference Design

Data Center contribution continues strong with three drivers: (a) IBM FlashCore Module 4 (FCM4) ongoing; (b) IBM FCM5 newly contributing (the successor product); (c) top-5 hyperscale operators using a RAID reference design. The "top-5 hyperscale" disclosure is the breadth signal — Everspin's parts are designed into RAID architectures at multiple cloud providers.

"In Data Center, growth continues to be driven by our ongoing work with IBM on the FCM4 and FCM5 modules and the Redundant Array of Independent Disks or RAID, reference design at the top 5 hyperscale operators." — Sanjeev Aggarwal, CEO

Assessment: Data Center is the steady-state large contributor. We model it as $18-22M of FY26 revenue, growing 10-12% YoY on FCM5 ramp + continued hyperscale RAID demand.

5. UNISYST MRAM Family Formally Introduced at Embedded World

The UNISYST family of MRAM products was formally introduced at Embedded World in early March 2026. The product positioning: unified code-and-data memory in a high-density nonvolatile architecture for embedded systems. Engineering samples expected Q4 2026; production 2027. The CEO's framing positions UNISYST as the multi-billion-dollar TAM expansion lever.

"During the quarter, we formally introduced our UNISYST MRAM family at Embedded World in early March. This product family represents a new generation of unified memory solutions designed to fundamentally change how embedded systems store and access code and data. UNISYST delivers high-bandwidth read and write speeds in a nonvolatile memory device, enabling fast boot, rapid updates and predictable performance without the trade-offs of traditional flash-based designs... Everspin will initially offer the UNISYST family in densities ranging from 128 megabits to 2 gigabits using a standard xSPI interface operating up to Octal SPI at 200 megahertz. Target use cases include AI at the edge, military and aerospace, automotive, industrial and casino gaming. Engineering samples of UNISYST are expected to be available in the fourth quarter of 2026... As a reminder, the UNISYST family of products will serve the high-density stand-alone NOR Flash market, which will expand our addressable market by approximately $3 billion. Our goal is to capture 5% to 10% of this market in the early years and then grow further." — Sanjeev Aggarwal, CEO

The formal introduction at Embedded World is the marketing/positioning milestone; the engineering-sample Q4 2026 and production 2027 timeline matches prior guidance. The 5-10% market share target on a $3B TAM = $150-300M of UNISYST-specific revenue opportunity over multiple years post-launch.

Assessment: UNISYST timing is on track. The Embedded World introduction is the structural validation that the product family is real and customer-evaluatable. Revenue contribution begins meaningfully in late 2027 / early 2028.

6. Microchip Foundry Services Agreement — Capex Ramping

The 10-year Microchip Foundry Services Agreement (manufacturing MRAM and TMR sensor products at Microchip's Oregon fab) is in the early capex investment phase. The CFO disclosed "significant capital spend over the next 2 years" related to this agreement. First product shipments from the new line are expected in H2 2027.

The strategic significance: provides Everspin with a second domestic source of MRAM manufacturing capacity, complementing the existing Chandler facility. This is critical for U.S. defense customers (validated by the new $40M subcontract) and supports the multi-year revenue acceleration thesis.

Assessment: The Microchip agreement is multi-year capex investment with H2 2027 revenue start. FY26 cash drag from Microchip-related capex is the central balance-sheet risk; FY27 cash recovery as the capex tapers and Microchip-line revenue begins is the structural offset.

7. PERSYST 128Mb / 256Mb High Reliability Parts

The 64Mb xSPI STT-MRAM HR ramped to full production in Q4 2025; the 128Mb and 256Mb high reliability variants are in qualification with H2 2026 high-volume availability target. Customers have engineering samples in hand.

"With respect to the high reliability parts that we announced last quarter, customers have our PERSYST 64-megabit xSPI STT-MRAM devices in hand and are engaged in design activity. Additionally, we remain on track to qualify our 128-megabit and 256-megabit high reliability parts and continue to expect them to be available in high volume in the second half of this year. Customers have engineering samples of these parts on hand as they evaluate them in their designs." — Sanjeev Aggarwal, CEO

Assessment: The HR variant roadmap is on track. The 128Mb/256Mb additions in H2 2026 are the FY26-27 revenue contributors. We model these adding $3-6M of FY26 revenue and $8-15M of FY27 revenue as production ramps.

8. Patent Litigation $1.6M/Quarter Continuing

The patent litigation cost overhang continues at ~$1.6M per quarter — the CFO confirmed it will continue "in that range for at least the next couple of quarters." This is now formally excluded from non-GAAP results in addition to SBC. The GAAP cost remains real.

"On your second question, we do show the $1.6 million that we had to expend in Q1 on litigation costs. And what I would say is, unfortunately, litigation is expensive, and I think we're kind of expecting it to continue in that range for at least the next couple of quarters. But again, we'll see how that ultimately pans out." — Bill Cooper, CFO

Assessment: Patent litigation is a meaningful but bounded GAAP-EPS drag through FY26 H1. At $1.6M/Q for 2-3 more quarters, the cumulative drag is $3-5M = $0.13-0.21 GAAP EPS impact over the remainder of FY26. Non-GAAP exclusion limits the operating impact. We don't treat litigation as a thesis risk; it's a discrete event with a finite resolution path.

9. UNISYST Family Revenue Timeline Clarification

The CEO clarified the UNISYST family revenue timeline in response to an analyst question. UNISYST is NOT a meaningful FY26 contributor; the production-volume ramp is 2027 with material contribution starting 18-24 months after that (i.e., FY28-FY29). The CEO's framing aligned with our prior modeling.

"I don't think that UNISYST is going to strongly contribute to the $100 million target that we have in the next 3 to 5 years. And the reason being that it takes about 18 to 24 months for the qualification of these products at our customers. So let's say, we have the product available samples in Q4 of '26, production, let's say, Q1 or Q2 of '27, and you basically have another 18 months before it's going to ramp to production. So I don't think it's going to contribute significantly, but it will contribute some." — Sanjeev Aggarwal, CEO

Assessment: UNISYST is FY28+ revenue contribution. The $100M revenue target is achievable WITHOUT UNISYST contribution if PERSYST + Toggle + new defense subcontract + Microchip Foundry Services compound at their current rates. UNISYST is the optionality lever beyond $100M.

Guidance & Outlook

The Q2 26 guide is the cleanest sequential acceleration signal we have. The +7% QoQ midpoint is well above the trailing four-quarter pattern (Q3 +7%, Q4 +5%, Q1 +0.7%). Critically, the guide EXCLUDES the $40M subcontract — meaning Q2 has real upside potential to $16.5M+ if the subcontract begins contributing in the quarter. The non-GAAP EPS guide of $0-$0.03 is well below the trailing EPS line ($0.06-0.11), but this reflects (a) planned OpEx step-up on Microchip Foundry Services + R&D + commercial team expansion, (b) gross margin pulling back from the Q1 52.7% peak to the structural 50% range, and (c) the $1.6M/Q litigation drag continuing.

Implied FY26 trajectory: Q1 $14.9M + Q2 ~$16M + Q3 ~$17M + Q4 ~$18M (including subcontract contributions building) = $65-72M FY26 revenue (+18-31% YoY). FY26 non-GAAP EPS likely $0.30-0.45 depending on OpEx + subcontract margin profile. Street at: Pre-print FY26 consensus was $60-62M; post-print rebase to $65-70M likely. Guidance style: Pattern continues — high end of guide on revenue; explicitly conservative on EPS to leave room for execution.

Analyst Q&A Highlights

$40M Subcontract Revenue Shape and Achievability

The opening question of Q&A pressed on the revenue shape of the new $40M subcontract — how does it layer in, what are the milestone risks, where does it sit in the revenue lines. The CFO's response was deliberately measured — no formal guidance yet, but high confidence in milestone achievement.

Q: "So the $40 million contract that you just announced, could you give us like a shape on how you're thinking that revenue layers in? Or anything you can share on the milestone payments such as how achievable you think the milestones are? What are the biggest risks to the milestones? And then lastly, will that revenue live in the licensing royalty patent bucket?"
— Neil Young, Needham & Company

A: "Yes, Neil, this is Bill. Thanks for the question. Yes, so we really aren't giving any guidance related to that particular subcontract agreement just yet. But of course, we do expect to have a significant positive impact over the next 2.5 years to the financials. In terms of meeting and achieving the milestones, yes, that was negotiated with the group involved, and we're very confident in our ability to deliver on the milestones."
— Bill Cooper, CFO

Assessment: The CFO's "significant positive impact over the next 2.5 years" + "very confident in our ability to deliver on the milestones" is as forward-leaning as the company is comfortable being on a new contract. The deliberate non-quantification preserves optionality on Q2 results — better to under-promise and beat than to commit to specific contribution and risk timing slippage. We model the subcontract at $4M per quarter starting Q3 ramping to $4-5M per quarter steady-state through FY28.

Gross Margin Strength Sustainability

The follow-up question pressed on the gross margin expansion vs management's prior cautious framing. The CFO acknowledged the strength but maintained the "50% plus" structural framing — confirming the operational drivers without resetting structural expectations higher.

Q: "Could you maybe speak to what drove the gross margin strength in the quarter? As the STT portfolio continues to evolve, are you maybe starting to see higher ASPs come through here? And then also, should we sort of expect to see this gross margin — the gross margin hold in this range or revert back to similar levels of 4Q '25?"
— Neil Young, Needham & Company

A: "Yes, good question. I think a couple of things, right? So the first is strong quarter on the margins. Again, as we've sort of always noted, we do target 50% plus in terms of gross margin. I think as we sort of see that lift in the top line and that volume increase, right, you kind of get into that beneficial arena of higher capacity utilization and obviously, right, the guys are always looking at ways to reduce costs and improve our yields. So all those things factor in."
— Bill Cooper, CFO

Assessment: The "50% plus" framing has subtly evolved from prior quarters' "45-50% structural range" — a forward signal that management is now anchoring expectations at 50%+ rather than 45-50%. With Q1 at 52.7% and the structural drivers (yield improvement + capacity utilization) sustaining, we model FY26 gross margin at 51-52% — a meaningful upgrade vs prior expectations of 50%.

$40M Subcontract Margin Profile and Strategic Context

The Craig-Hallum analyst pressed on the margin profile of the new subcontract and how it relates to the broader portfolio of defense-related contracts (DoD sustainment, Microchip Foundry Services, potential 300mm MRAM line work).

Q: "I'm going to follow up on this $40 million contract here. I guess a few questions here for me. I want to follow up from your response, Bill here about why you don't have any revenue thoughts here you can give today, is that because you're not allowed to or because you don't know what the shape and structure and timing looks like? And then also, I want to get a sense of what kind of margin profile we should expect over the life of the contract with this... Can you kind of tie these things together or if they're not tied together, tell us?"
— Richard Shannon, Craig-Hallum Capital Group

A: "Thanks. Yes, good questions. So I'll try and elaborate a little bit further. The contract itself, right, the ink on that is just drying. And obviously, it's going to have a significant impact on the financials. And so we're looking at all of the various impacts of that. And as we run through Q2 and get the results and get the kickoff of the contract and all the various pieces, right, we'll give you guys better guidance as we go into the end of this Q2 results. And then in terms of margin, yes, I would expect that, that is also going to have a bit of a beneficial impact to margin as well. And — but again, that's sort of — I have to be a little careful there. We're going to, again, reiterate, we do target the 50% plus margin for gross margins. And again, we have to sort through all the pillars of that significant contract... I think maybe I can help and then maybe there's a follow-on to further clarify. But the bottom line is the RFI for the 300-millimeter MRAM line is independent of the 3 other items you mentioned, namely the $14.6 million contract that we got in 2024, the Microchip Foundry Services Agreement and the new contract that we just talked about today."
— Bill Cooper, CFO & Sanjeev Aggarwal, CEO

Assessment: The CFO's "beneficial impact to margin as well" framing on the new subcontract is the most important margin-related signal. Engineering services + technology recipe development typically carry 60-80% gross margins — well above product gross margin. The CEO's structural map of the four distinct defense relationships (1. $14.6M DoD sustainment, 2. Microchip Foundry Services, 3. $40M subcontract, 4. potential 300mm MRAM line RFI) is the cleanest portfolio framing we have heard. The 300mm MRAM line opportunity is referenced for the first time — a potential additional contract.

Q2 Guidance Composition

The follow-up question pressed on the Q2 guide composition — how much is product vs services, and what's the litigation cost trajectory.

Q: "I will jump back into the queue, and that's really about the guidance here. So I mean, it sounds like we should expect most of the sequential growth in dollar terms here to come from products here. How do we think about it between the kind of the STT that's mostly going to IBM versus other products here within that? And then any idea — or can you just give us a sense of what kind of litigation spend you're expecting in the second quarter?"
— Richard Shannon, Craig-Hallum

A: "So on the first point, what I would say is definitely seeing very strong product sales. We're up year-on-year 28%. I think most of that growth from Q1 to Q2 is going to be in that product sales category. Again, we are seeing, I would say, just good solid product sales across all the various categories. And then on your second question, we do show the $1.6 million that we had to expend in Q1 on litigation costs. And what I would say is, unfortunately, litigation is expensive, and I think we're kind of expecting it to continue in that range for at least the next couple of quarters. But again, we'll see how that ultimately pans out."
— Bill Cooper, CFO

Assessment: Q2 sequential growth is product-driven — consistent with our model that the new defense subcontract will start contributing meaningfully in Q3 rather than Q2. The litigation cost trajectory at $1.6M/Q is bounded — "at least the next couple of quarters" implies Q2 + Q3 with potential resolution in Q4. Cumulative drag through FY26: $4-5M total.

Capex Trajectory and Microchip Foundry Services Spending

The Q&A continued on capital expenditure — Everspin's CapEx has been above-trend through the prior two quarters. The CFO confirmed the trend is related to the Microchip Foundry Services Agreement and will continue for the next 2 years.

Q: "I noticed you've had a couple of quarters of some above-trend CapEx numbers in the fourth quarter and now the first here. And while I could certainly expect some of that coming from maybe your Microchip agreement or not, I'm not sure. But how do we look at that going forward here?"
— Richard Shannon, Craig-Hallum

A: "Yes, we did. We had a, I'll call it, a unique period of capital spend. And that, again, was related to some of the improvements that we saw in the Chandler facility primarily across a couple of different contracts. So that flurry of activity, I think, will start to settle down until we get into the real heart of this Foundry Services Agreement... there will be some significant capital spend over the next 2 years. Again, it's going to be spread out over time a little bit, probably some later this year as well as early next year. And then in terms of the overall CapEx, not so significant that we can't manage it. I think, again, it's going to be in the range of kind of what our historical spend has been annually."
— Bill Cooper, CFO

Assessment: The capex pressure continues through 2026-2027 for Microchip Foundry Services. The CFO's framing "in the range of kind of what our historical spend has been annually" suggests ~$15-20M/year capex through 2026-2027 (vs ~$8-10M/year historical). This is the central FY26 cash trajectory variable. We model FY26 cash exit at $32-36M (down from $40.5M Q1 26 exit).

UNISYST Revenue Contribution Timeline

The closing question pressed on the UNISYST family revenue timeline — specifically how it ties to the $100M revenue target. The CEO's response confirmed that UNISYST is FY28+ revenue contribution, not a FY26-27 catalyst.

Q: "You talked about a goal of driving towards or driving to $100 million of revenues within, I think, 3 to 5 years. I look at that 5% to 10% share early on, 'early on' seems to be a little bit longer time frame than what would fit in here. So are we either thinking it's going to take a while to get that kind of share? Or is there some meaningful upside in terms of timing to hit that $100 million total corporate level goal?"
— Richard Shannon, Craig-Hallum

A: "Yes, that's a good question for clarification, Richard. So I think we have talked about this in the past. I don't think that UNISYST is going to strongly contribute to the $100 million target that we have in the next 3 to 5 years. And the reason being that it takes about 18 to 24 months for the qualification of these products at our customers. So let's say, we have the product available samples in Q4 of '26, production, let's say, Q1 or Q2 of '27, and you basically have another 18 months before it's going to ramp to production. So I don't think it's going to contribute significantly, but it will contribute some."
— Sanjeev Aggarwal, CEO

Assessment: UNISYST is FY28+ revenue. The $100M target is achievable without meaningful UNISYST contribution if PERSYST + Toggle + new defense subcontract + Microchip Foundry Services compound at their FY26 trajectory. UNISYST is the optionality lever beyond $100M.

What They're NOT Saying

1. $40M subcontract Q2-Q3 revenue contribution: "Significant positive impact" confirmed; no dollar contribution by quarter disclosed. We model $4M per quarter starting Q3.
2. $40M subcontract margin profile specifics: "Beneficial impact to margin" framing only. We estimate 60-80% gross margin on the engineering services component.
3. Prime contractor identity: The U.S. prime contractor is not named. Likely candidates: Lockheed Martin, Raytheon (RTX), Northrop Grumman, General Dynamics, L3Harris, Boeing.
4. 300mm MRAM line RFI status: CEO referenced this as an independent opportunity. No timeline or sizing disclosed.
5. FY26 revenue or EPS guidance: Quarterly only. No formal FY26 commitment.
6. Specific xSPI 128Mb / 256Mb HR Q4 launch design wins: Engineering samples confirmed in customer hands; no specific customer disclosure.
7. Microchip Foundry Services Agreement total capex: "Significant capital spend over the next 2 years"; no dollar total.
8. NOR Flash conversion conversation status: Q4's NOR Flash supply-chain tailwind narrative was not surfaced in Q1 — likely intentional given the focus on the $40M subcontract announcement. Still active opportunity but not Q1 emphasis.
9. Quintauris partnership revenue update: No specific commentary on Quintauris (RISC-V automotive reference designs) progress.
10. Patent litigation plaintiff/defendant identity: Still not disclosed. Resolution timeline still "at least next couple of quarters."

Market Reaction

• Pre-print setup (Apr 28 close): $12.74. Stock had recovered +40% from Q4 print close ($9.12 Mar 5) and +56% from Mar 30 trough ($8.16). Positioning was constructive but not euphoric — most of the recovery had priced FY26 normalization, not the $40M subcontract surprise. Average daily volume 500-800K (rising from Q4 levels).
• Day-of action (Apr 29 — print released after-market): Regular hours close $13.19 (+0.23% from Apr 28); volume 937.8K. The $40M defense subcontract announcement + Q1 print were released after-market simultaneously. After-hours initial reaction was sharply positive — stock printed up +30-40% in extended hours on the magnitude of the subcontract announcement combined with the operational beat and Q2 sequential acceleration.
• T+1 (Apr 30): Open $18.06 (gap UP +37% from Apr 29 close); intraday high $19.71; intraday low $16.50; close $18.28 (+38.6% from Apr 29 close). Volume 14,317,300 shares — ~30x trailing 30-day average. The largest single-day volume in Everspin's history. Stock closed at 93% of intraday high, signaling buyer-driven flow throughout the session.
• T+2 (May 1): Open $18.30; intraday high $22.69 (+24% intraday); close $21.49 (+17.43% from Apr 30). Volume 4,693,400 (~9x normal). The continuation move validates the re-rate as structural rather than tactical.
• Sell-side reaction:
  • Needham (Neil Young): Upgrade to Buy from Hold; PT raised to ~$25 (estimated)
  • Craig-Hallum (Richard Shannon): Upgrade to Buy from Hold; PT raised to $22-24 (estimated)
  Both desks cited the $40M subcontract as a thesis-changing event AND the sustained product growth + gross margin expansion as supporting evidence.
• Peer reaction: SOXX up modestly Apr 30 (+0.5%) on broader chip strength. No clear sector read-through — MRAM traded on its idiosyncratic catalyst.

The Q1 2026 reaction is structurally different from any prior quarter in our coverage. Q2 2025 was -6% close on intraday reversal; Q3 2025 was +6.7% print-day, -8% T+1 reversal; Q4 2025 was -8.5% T+1 on flat guide. Q1 2026 was +38.6% T+1 followed by +17% T+2 — a clean re-rating that doubled the stock vs pre-print over 2 days. The +68% from Apr 28 pre-print close to May 1 close is the structural step-change in market perception that the $40M subcontract triggered.

The 30x volume on T+1 + 9x volume on T+2 signals wholesale institutional repositioning. Growth-fund managers initiating positions; momentum funds chasing; retail discovery accelerating. This is the kind of step-change in institutional ownership profile that typically supports a multi-quarter higher trading range. We don't expect the stock to round-trip back to pre-print levels absent a specific thesis-breaking event.

Street Perspective

Debate: Is the $40M subcontract priced in at $18-22?

Bull view: At $40M / 2.5 years = $16M annualized = ~30% lift to current revenue run-rate at high-margin service economics. The contract validates Everspin's positioning as the U.S. government-designated MRAM partner, which typically compounds into multi-decade defense-industrial relationships. The +68% stock move from $12.74 to $21.49 prices roughly 1.5x of the contract value as enterprise value uplift ($200M of incremental market cap at $9 stock per fully-diluted share basis), which is conservative given the multi-year revenue visibility and the strategic-positioning compounding value. Additional contracts of similar or larger size are plausible over the next 2-3 years given the validated relationship.

Bear view: The $40M subcontract value is $16M annualized — meaningful but not transformational. The market is pricing $200M+ of incremental enterprise value, implying 12.5x the annual revenue contribution — too aggressive without follow-on contract visibility. The qualification cycles for new defense contracts are 18-36 months; the implicit assumption that this is the first of many similar-sized contracts is speculative. At $21, the stock embeds significant FY27-28 follow-on contract expectations that may not materialize.

Our take: The bull case is more probable but the bear case warrants discipline on position sizing. We initiate at fair value $24-30 over 12 months, reflecting the structural re-rate AND the follow-on contract optionality. Position sizing remains microcap-appropriate (1-3% max) given liquidity — the move from $12 to $21 demonstrates how quickly the stock can move on news, in either direction.

Debate: Is the gross margin expansion structural or cyclical?

Bull view: Five consecutive quarters above 50% gross margin (Q1 25 51.4% → Q1 26 52.7%) with Q1 26 the highest of the run is structurally validating. Yield improvements + capacity utilization are real operational drivers. The new $40M subcontract has "beneficial impact to margin" per CFO — engineering services revenue carries 60-80%+ gross margin. The structural floor is materially higher than the historical 45-50% framing. FY26 gross margin will sustain at 51-53%; FY27+ could expand toward 55%+ as engineering-services mix grows.

Bear view: The Q1 52.7% peak is a multi-driver convergence (capacity utilization + yield + mix) that won't sustain. Q2 guidance implicitly assumes 50-51% (modest compression from Q1). The CFO's continued "50% plus" framing is deliberate caution — management knows the structural product margin is in the 45-50% range; recent quarters have been above-trend on mix and utilization. Gross margin will revert to the 49-51% range over the next 2-3 quarters as licensing mix continues to normalize.

Our take: Reality is between the two views. We model FY26 gross margin at 51% (vs FY25 50.8% actual) and FY27 at 51-52% with engineering services mix building. The structural improvement is real but bounded; we don't extrapolate to 55%+ without more data.

Debate: Will follow-on defense contracts materialize over 2026-2028?

Bull view: Everspin now has four distinct defense relationships compounding: (1) $14.6M DoD sustainment contract, (2) $40M new subcontract, (3) Microchip Foundry Services 10-year manufacturing agreement, (4) potential 300mm MRAM line work referenced by the CEO. Each agreement seeds opportunities for the next. The pattern: small initial contract → trust-building over 2-3 years → larger follow-on contracts. The 300mm MRAM line RFI mentioned on this call is the next visible opportunity; additional defense-industrial customers (driven by ITAR concerns + Buy American requirements) are likely candidates.

Bear view: Defense contracts are individually large but lumpy. The $40M subcontract took 18+ months of relationship-building to convert; follow-on contracts of similar size will take similar timelines. Realistic follow-on contract pace: one $20-40M contract per 18-24 months — meaningful but not exponential. Modeling FY27-28 with multiple new contracts layering is too aggressive.

Our take: The bull case timeline is optimistic but the structural relationship-building is real. We model one follow-on contract of $30-50M starting late 2027, contributing $5-8M annual revenue at full ramp. The $300mm MRAM line opportunity is the next visible RFI; if it materializes, it could be a separate $40-80M+ contract. We treat these as optionality, not base-case revenue.

Model Update Needed

Valuation impact: At Apr 30 close of $18.28 and ~23.1M diluted shares, market cap is ~$422M; cash $40.5M, debt $0, EV ~$382M. On FY26E revenue of $70M and non-GAAP EPS of $0.40 ($9.2M net income), MRAM trades at 5.5x EV/Sales and ~42x EV/NI. On FY27E revenue of $87M and non-GAAP EPS of $0.65 ($15M net income), MRAM trades at 4.4x EV/Sales and ~25x EV/NI. The multiple has expanded significantly from Q4 (2.9x EV/Sales) reflecting the thesis transition + earnings ramp. Specialty-semi peers in defense-adjacent verticals (Mercury Systems, AVAV, Kratos) trade at 4-7x EV/Sales and 25-40x EV/NI for similar growth profiles. Our 12-month fair-value estimate: $24-30 (31-64% above Apr 30 close), with upside to $35+ on follow-on defense contract wins, meaningful NOR Flash conversion materialization, or Microchip Foundry Services contribution earlier than 2027.

Thesis Scorecard Post-Earnings

Overall: The thesis has structurally evolved. Three of the prior bear cases (gross margin compression, design-win-to-revenue lag, structural revenue acceleration) have been resolved positive. Two new bull pillars (the $40M subcontract validating compounding moat; the Transportation/Rail vertical with SIL4 use case) have emerged. The two remaining bear concerns (cash trajectory, microcap liquidity) are addressable: cash will be sufficient through FY26; liquidity is improving rapidly post-print.

Action: Upgrading to Outperform from Hold. The Q1 print is the strongest operational quarter of our coverage AND introduces a thesis-changing strategic event. The structural narrative has transitioned from "speculative microcap with strong design-win pipeline" to "U.S. government-validated MRAM franchise with structural defense-relationship moat." Position sizing remains microcap-appropriate (1-3% max) given liquidity considerations, but the conviction level has stepped up materially. Re-downgrade trigger: Q2 26 revenue prints below $15M (low end of guide) OR Q3 26 product growth decelerates below +20% YoY OR $40M subcontract milestones are missed. Position-expansion trigger: Q2 26 prints at $16.5M+ revenue (top of guide) WITH initial subcontract contribution disclosed AND additional follow-on defense contract announced.